Experimental paracetamol nephropathy and pyelonephritis in rats

Area of Science:

• Nephrology
• Toxicology
• Pharmacology

Background:

• Paracetamol (acetaminophen) is a widely used analgesic and antipyretic.
• Analgesic nephropathy is a serious clinical condition associated with chronic pain reliever use.
• The specific role of paracetamol in inducing nephropathy, especially in compromised kidneys, requires further investigation.

Purpose of the Study:

• To investigate the nephrotoxic potential of paracetamol in rats with experimentally induced pyelonephritis.
• To compare the renal effects of paracetamol in healthy versus pyelonephritic rats.
• To identify pathological changes that may correlate with clinical analgesic nephropathy.

Main Methods:

• Rats were administered paracetamol (300 mg/kg/day) for up to 32 weeks.
• Experimental pyelonephritis was induced in a subset of rats.
• Renal tissues were examined histopathologically for lesions and specific pathological markers.

Main Results:

• Paracetamol administration led to significant renal lesions in rats with pyelonephritis.
• The same dose of paracetamol did not induce renal lesions in healthy rats.
• Pyelonephritic reactions were more severe in rats treated with paracetamol compared to controls.
• Histopathological findings included thickened microvessel and tubular basement membranes, papillary necrosis, and attempted healing of necrotic tissue.

Conclusions:

• Paracetamol can potentiate nephrotoxicity in the presence of pre-existing kidney disease, such as pyelonephritis.
• The observed pathological changes in rats resemble those seen in human analgesic nephropathy.
• These findings highlight the potential risk of paracetamol in patients with renal impairment.